Differential Expression of FGFRs Signaling Pathway Components in Bladder Cancer: A Step Toward Personalized Medicine

Variations Improper activation and inappropriate expression of fibroblast growth factor receptors (FGFRs) in cancer suggests that they can act as therapeutic targets. Fibroblast growth factor receptor inhibitors are currently employed in clinical trials of different cancers. Regarding the essence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ousati Ashtiani, Z, Tavakkoly-Bazzaz, J, Salami, SA, Pourmand, MR, Mansouri, F, Mashahdi, R, Pourmand, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972506/
https://www.ncbi.nlm.nih.gov/pubmed/29876236
http://dx.doi.org/10.1515/bjmg-2017-0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972506/
https://www.ncbi.nlm.nih.gov/pubmed/29876236
http://dx.doi.org/10.1515/bjmg-2017-0026

Ejemplares similares